All In MedTech

FDA Clearance Tracker · P920014-S029

THORATEC HEARTMATE XVE LVAS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 13, 2009 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 13, 2009

Approved

Time to decision

239 days

Received Jul 17, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P920014-S029
Device name
THORATEC HEARTMATE XVE LVAS
Applicant
Thoratec Corp
Applicant location
Pleasanton, CA
Received
Jul 17, 2008
Decided
Mar 13, 2009
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P920014

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code DSQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MODIFICATIONS TO THE EXTERNAL PERIPHERALS.

Source documents

Other decisions for Thoratec Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.